James K. Campbell, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 15190 Community Rd Ste 240, Gulfport, MS 39503 Phone: 228-575-7104 Fax: 228-539-6766 |
Dr. Hans Werner Adams, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 4500 West Railroad Street, Gulfport, MS 39503 Phone: 228-863-8836 Fax: 228-864-4417 |
Dr. Eric Vincent Plott, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 15190 Community Rd Ste 230, Gulfport, MS 39503 Phone: 228-575-7104 Fax: 228-539-6766 |
Dr. Navin V Barot, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1340 Broad Ave Ste 300, Gulfport, MS 39501 Phone: 228-575-2700 Fax: 228-575-2710 |
News Archive
Infant vernier acuity is not as immature as previous research has indicated according to a study published in March in the Journal of Vision, an online, free access publication of the Association for Research in Vision and Ophthalmology (ARVO).
Researchers of Ludwig-Maximilians-Universitaet in Munich have shown that a protein called midkine, a member of the class of signaling molecules known as cytokines, is a key driver of inflammation in the heart muscle that can lead to heart failure in patients with myocarditis.
Teva Pharmaceutical Industries Ltd. today announced the publication of data from the 15-year clinical study with Copaxone® (glatiramer acetate injection), which is the longest prospective and continuous evaluation ever conducted in relapsing-remitting multiple sclerosis (RRMS) patients. The data were published in the February issue of the journal Multiple Sclerosis.
Responding to increased demand for technology to help prevent potentially fatal catheter-related bloodstream infections (CRBSIs), Cook Medical has expanded its Spectrum Turbo-Ject line of antibiotic impregnated peripherally inserted central venous catheters (PICCs) to treat a wider range of patient needs. For the first time, the clinical benefits of minocycline and rifampin-impregnated PICCs, a critical component in eliminating 250,000 potentially fatal CRBSIs in the U.S. annually, are now available in 3 French single and 6 French triple lumen sizes.
Actavis plc, a leading global specialty pharmaceutical company committed to infectious disease treatment innovation, today announced the creation of SHARE ID (Sharing Hospital data to Advance Research and Enhance patient care in Infectious Diseases), a collaborative program to leverage real-world data to advance the delivery and effectiveness of care for patients with serious infections due to antibiotic-resistant pathogens.
› Verified 9 days ago